Echosens has received US FDA approval for its FibroScan ® device and the company is planning to introduce this technology in the US market for the first time. Currently 1800 FibroScan devices are used ...

This milestone opens a path for FibroScan ® to ultimately replace liver biopsy for patient enrollment and treatment response assessment in MASH drug development WESTBOROUGH, Mass., Sept. 8, 2025 ...